Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram Reddy

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Medicinal Chemistry|January 6, 2012
Montmorillonite K-10 mediated green synthesis of cyano pyridines: Their evaluation as potential inhibitors of PDE4T Ram Reddy, G Rajeshwar Reddy, L Srinivasula Reddy, et al.
Gene|December 26, 2012
Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer riskShree Divyya, Shaik Mohammad Naushad, Anthony Addlagatta, et al.
Alzheimer'S Research & Therapy|January 22, 2022
A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitroIsabelle Aillaud, Senthilvelrajan Kaniyappan, Ram Reddy Chandupatla, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Crystal structures of KPC-2 β-lactamase in complex with 3-nitrophenyl boronic acid and the penam sulfone PSR-3-226Wei Ke, Christopher R Bethel, Krisztina M Papp-Wallace, et al.
Gene|February 8, 2012
Paradoxical role of C1561T glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibilityShree Divyya, Shaik Mohammad Naushad, Anthony Addlagatta, et al.
Chemmedchem|March 23, 2012
The importance of the trans-enamine intermediate as a β-lactamase inhibition strategy probed in inhibitor-resistant SHV β-lactamase variantsWei Ke, Elizabeth A Rodkey, Jared M Sampson, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2010
Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacyMicheal Nottingham, Christopher R Bethel, Sundar Ram Reddy Pagadala, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2010
Penicillin sulfone inhibitors of class D beta-lactamasesSarah M Drawz, Christopher R Bethel, Venkata R Doppalapudi, et al.
Biology Open|July 10, 2024
Safety assessment of rat embryonic fraction for in vivo regenerative therapySivarama Prasad Darsi, Somorita Baishya, Veerababu Nagati, et al.
Journal of the American Chemical Society|September 9, 2010
Design, synthesis, and crystal structures of 6-alkylidene-2'-substituted penicillanic acid sulfones as potent inhibitors of Acinetobacter baumannii OXA-24 carbapenemaseGerman Bou, Elena Santillana, Anjaneyulu Sheri, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Medicinal Chemistry|January 6, 2012
Montmorillonite K-10 mediated green synthesis of cyano pyridines: Their evaluation as potential inhibitors of PDE4T Ram Reddy, G Rajeshwar Reddy, L Srinivasula Reddy, et al.
Gene|December 26, 2012
Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer riskShree Divyya, Shaik Mohammad Naushad, Anthony Addlagatta, et al.
Alzheimer'S Research & Therapy|January 22, 2022
A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitroIsabelle Aillaud, Senthilvelrajan Kaniyappan, Ram Reddy Chandupatla, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Crystal structures of KPC-2 β-lactamase in complex with 3-nitrophenyl boronic acid and the penam sulfone PSR-3-226Wei Ke, Christopher R Bethel, Krisztina M Papp-Wallace, et al.
Gene|February 8, 2012
Paradoxical role of C1561T glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibilityShree Divyya, Shaik Mohammad Naushad, Anthony Addlagatta, et al.
Chemmedchem|March 23, 2012
The importance of the trans-enamine intermediate as a β-lactamase inhibition strategy probed in inhibitor-resistant SHV β-lactamase variantsWei Ke, Elizabeth A Rodkey, Jared M Sampson, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2010
Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacyMicheal Nottingham, Christopher R Bethel, Sundar Ram Reddy Pagadala, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2010
Penicillin sulfone inhibitors of class D beta-lactamasesSarah M Drawz, Christopher R Bethel, Venkata R Doppalapudi, et al.
Biology Open|July 10, 2024
Safety assessment of rat embryonic fraction for in vivo regenerative therapySivarama Prasad Darsi, Somorita Baishya, Veerababu Nagati, et al.
Journal of the American Chemical Society|September 9, 2010
Design, synthesis, and crystal structures of 6-alkylidene-2'-substituted penicillanic acid sulfones as potent inhibitors of Acinetobacter baumannii OXA-24 carbapenemaseGerman Bou, Elena Santillana, Anjaneyulu Sheri, et al.
Pageof 9